References
- Mccullough J. The role of the blood bank in transplantation. Arch Pathol Lab Med 1991;115:1195–1200
- Warkentin PI. Transfusion of patients undergoing bone marrow transplantation. Hum Pathol 1983;14:261–266
- Mccullough J, Lasky LC, Warkentin PI. Role of the blood bank in bone marrow transplantation. Prog Clin Biol Res 1984;149:379–412
- Brand A, Claas FH, Falkenburg JH, Blood component therapy in bone marrow transplantation. Semin Hematol 1984;21:141–155
- Clift RA. Cellular support of marrow transplant recipient. Prog Clin Biol Res 1990;337:87–92
- Wulff JC, Santner TJ, Storb R, Transfusion requirements after HLA-identical marrow transplantation in 82 patients with aplastic anemia. Vox Sang 1983;44:366–374
- Weissinger F, Sandmaier BM, Maloney DG, Decreased transfusion requirement for patients receiving nonmyeloablative compared with conventional peripheral blood stem transplants from HLA-identical siblings Blood 2001;98(13):3584–3588
- Hollan SR. Transfusion-associated iron overload. Curr Opin Hematol 1997;4:436–441
- Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol 1997;34:34–40
- Klein HG. Transfusion in transplant patients: the good, the bad, and the ugly. J Heart Lung Transplant 1993;12:S7–12
- Wandt H, Schaefer-Eckart K, Wilheim M. Two allogeneic hematopoietic stem cell transplantations without the use of blood-product support. Haematologica 2005;90:1292–1294
- Ballen KK, Becker PS, Yeap BY, Autologous stem-cell transplantation can be performed safely without the use of blood product support. J Clin Oncol 2004;22:4087–4094
- Schetelig J, Breitschaft A, Kroger N, ; Co-operative Transplantation Study Group. After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than blood group B. Transfusion 2005;45(5);779–787
- Diedrich B, Remberger M, Shanwell A, A prospective randomized trial of a prophylactic platelet transfusion of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients. Transfusion 2005;45(7): 1064-1072
- Mazzas P, Prudenzano A, Amurri B, Myeloablative therapy and bone marrow transplantation in Jehovah's witnesses with malignancies: single center experience. Bone Marrow Transplant 2003;32:433–436
- Blajchman MA. Transfusion immunomodulation or TRIM: what does it mean? Hematology 2005;10(Suppl 1):208–214
- Blajchman MA. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. Vox Sang 1998;74(Suppl 2):315–319
- Vamvakas EC. WBC-containing allogeneic blood transfusion and mortality: a meta-analysis of randomized controlled trials. Transfusion 2003;43:963–973
- Gupta P, Leroy SC, Luikart SD, Long-term blood product transfusion support for patients with myelodysplastic syndrome (MDS): cost analysis and complications. Leukemia Res 1999;23:953–959